Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Heart Study Could Cost Twice Orexigen’s Market Cap
Forbes
Wednesday, February 2, 2011 - 8:44am
tags:
Orexigen, obesity, Contrave
Sanofi Diabetes Drug Worked as Well as Byetta in Study
Bloomberg
Wednesday, February 2, 2011 - 8:42am
tags:
Sanofi, diabetes, Byetta, lixisenatide, Amylin, Eli Lilly
GlaxoSmithKline sells stake in Quest for $1.7 bln
Marketwatch
Wednesday, February 2, 2011 - 8:40am
tags:
GSK, Quest
Earnings Preview: Merck to tout pipeline in report
Yahoo/AP
Wednesday, February 2, 2011 - 8:40am
tags:
Merck, earnings
Generic Risk Looms over Endo Pharma
Yahoo/Zacks.com
Tuesday, February 1, 2011 - 9:18pm
tags:
generics, Endo, Mylan, lidoderm
Analysts: Genzyme may fetch $77 a share
Bizjournals.com
Tuesday, February 1, 2011 - 9:15pm
tags:
Genzyme, Sanofi, M&A
Biogen 4Q profit drops 21 pct as expenses rise
Yahoo/AP
Tuesday, February 1, 2011 - 4:58pm
tags:
Biogen Idec, earnings
Why Qiagen's Earnings Are Outstanding
Motley Fool
Tuesday, February 1, 2011 - 4:57pm
tags:
earnings, Qiagen
Parexel Shares Plunged: What You Need to Know
Motley Fool
Tuesday, February 1, 2011 - 4:55pm
tags:
Parexel, Merck, Bristol-Myers Squibb
Sanofi Plans to Raise Genzyme Bid
NY Times, NY
Tuesday, February 1, 2011 - 4:53pm
tags:
M&A, Sanofi, Genzyme
Let It Snow, Let It Snow, I-P-O
InVivo
Tuesday, February 1, 2011 - 11:24am
tags:
Enycte, Pacira, AcelRx, IPOs
Obesity Drugs: The Road to Perdition
TheStreet.com
Tuesday, February 1, 2011 - 11:22am
tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa, Lorqess
Pfizer To Shrink R&D And Cut Up To 3,500 Jobs
Pharmalot
Tuesday, February 1, 2011 - 11:20am
tags:
Pfizer, layoffs, R&D
Sanofi, Takeda drugs on FDA early safety probe list
Reuters
Tuesday, February 1, 2011 - 11:19am
tags:
FDA, Takeda, Sanofi, Multaq, Actos
Pfizer To Halt Funding in Allergy, Respiratory, Urology Areas
Bloomberg
Tuesday, February 1, 2011 - 11:17am
tags:
allergies, urology, Respiratory, Pfizer
Pfizer Profit Beats Analyst Estimates on Lower Costs
Bloomberg
Tuesday, February 1, 2011 - 8:33am
tags:
Pfizer, earnings
Valeant to Buy PharmaSwiss for $481 Million
NY Times, NY
Tuesday, February 1, 2011 - 8:29am
tags:
Valeant Pharmaceuticals, PharmaSwiss, M&A
Roche Said to Return Diabetes Drug Rights to Ipsen
Bloomberg
Tuesday, February 1, 2011 - 8:25am
tags:
Ipsen, Roche, diabetes, taspoglutide
Time to Buy Into Stem Cells?
Motley Fool
Tuesday, February 1, 2011 - 8:23am
tags:
stem cells, Geron, Neuralstem, StemCells, Pfizer, GSK, Cephalon, Mesoblast, Merck, Alnylam
Clinical Data: Incredible Potential Even After a 50% Pop
Seeking Alpha
Tuesday, February 1, 2011 - 8:21am
tags:
Clinical Data

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.